Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products globally. It operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its pharmaceutical offerings include generics for conditions like pancreatic exocrine insufficiency, hypertension, hypothyroidism, and migraine, as well as anti-infectives and influenza vaccines. The diagnostics segment provides laboratory and transfusion medicine systems, molecular diagnostics (including PCR instrument systems), point-of-care testing for conditions like HIV, SARS-CoV-2, influenza, and strep A, and rapid lateral flow tests. Nutritional products include pediatric and adult nutritionals and infant formula. The Medical Devices segment covers rhythm management devices and other products.

Abbott Laboratories is listed on the New York Stock Exchange (NYSE) under the ticker symbol ABT. Its shares are traded in US dollars (USD). As a US-based company, its financial reporting is also in USD, making it accessible to investors in the United States and internationally through the NYSE.

Abbott Laboratories operates in the Healthcare sector, specifically within the Medical Devices industry. This classification reflects its primary focus on developing and manufacturing medical devices, diagnostics, nutritional products, and pharmaceuticals. The company's diverse portfolio spans multiple healthcare subfields, but its core industry designation is Medical Devices due to the significant revenue generated from devices like rhythm management products and diagnostic systems.

Abbott Laboratories is headquartered in the United States and serves global markets. Its products are sold worldwide, with a presence in both developed and emerging markets. The company's global reach is supported by its four business segments, which cater to diverse healthcare needs across regions. While specific headquarters city is not provided, its US base and international operations allow it to distribute pharmaceuticals, diagnostics, nutritionals, and medical devices to patients and healthcare providers around the world.

Abbott Laboratories generates revenue through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The pharmaceutical segment sells generic drugs for various conditions and vaccines. Diagnostics revenue comes from laboratory systems, molecular testing (e.g., PCR for infectious diseases), point-of-care tests, and rapid diagnostics. Nutritional products include infant formula and adult nutritional supplements. Medical Devices contribute through rhythm management and other device sales. This diversified model allows Abbott to capture value across multiple healthcare categories, reducing reliance on any single product line.